Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-007438

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
May 8, 2015
Accepted (ET)
May 8, 2015 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———1,750,000IBy Family Limited Partnership
Common Stockholding———1,491,453D
Common Stockholding———5,975IBy Spouse
Common Stockholding———33,775IBy Son: JK1
Common Stockholding———33,563IBy Daughter: EK
Common Stockholding———33,533IBy Son: JK2

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—May 8, 2015A70,000A——Common Stock70,00070,000D
Common Stock OptionsF2$8.01May 8, 2015A40,000AMay 8, 2015May 8, 2025Common Stock40,00040,000D

Explanation of responses